Show Notes
Skyrocketing stocks, eye-watering prices, looksmaxxing bodybuilders, this is the summer of huge markets both legal and illegal. This week on the show, Stacey and Max solve the case of the $8 ice cream cone, learn about the dicey gray market of peptides, and discover why you should always check your LinkedIn messages. See omnystudio.com/listener for privacy information.
More from Everybody's Business
As the midterms come into focus, venture capitalist Marc Andreessen keeps showing up on lists of the biggest political spenders. Bloomberg reporter Austin Carr shares the story of how a left-of-center software engineer turned into a Silicon Valley juggernaut with an army of lobbyists. Then we sit down with economist Isabella Weber to discuss her new book, Anti-Fascist Economics, and why she believes American democracy needs an about face to do right by its citizens. Plus: Merger Madness! See omnystudio.com/listener for privacy information.
Bloomberg’s daily news podcast Big Take recently released an episode about the meteoric and very lucrative rise of the “Romantasy” literary genre, which our reporters explored in a Businessweek story this fall. Please enjoy, and hop on over to subscribe to their feed if you like what you hear! ———————
Women’s sports are exploding in popularity and revenue, but which is up next to breakthrough? Businessweek reporter Amanda Mull went to Indianapolis to find out why the NFL believes that flag football will be America’s next monoculture moment. Plus, how would you feel if everyone paid a different price for a carton of eggs? Surveillance pricing is moving beyond the internet and into big box stores, and our very own Max Chafkin has the reporting behind the trend. See omnystudio.com/listener for privacy information.
Max and Stacey sit down with Tubi Chief Content Officer Adam Lewinson at Bloomberg's Screentime conference in Los Angeles, where they discuss price hikes by the major streaming services and the state of the ad-supported alternatives. Plus, Ashley Carman drops in before her interview with Conan O'Brien to fill us in on the new podcasting gold rush. See omnystudio.com/listener for privacy information.
GLP-1s, touted as a miracle drug by many, are slowly disappearing from Americans' insurance plans. Bloomberg workplace reporter Taylor Nicole Rogers explains why companies are saying “no thanks” to one of the hottest classes of pharmaceuticals on the market. And then, what would you do if you were in $30,000 of credit card debt? Debt Heads podcast co-host Jamie Feldman gives her negative balance a casual shrug, and makes the argument that you should too. See omnystudio.com/listener for privacy information.